• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Pathogenesis elucidation of seronegative spondyloarthritis using patient-derived iPSCs

Research Project

Project/Area Number 16K15663
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Orthopaedic surgery
Research InstitutionKyoto University

Principal Investigator

Yoshitomi Hiroyuki  京都大学, ウイルス・再生医科学研究所, 准教授 (50402920)

Co-Investigator(Kenkyū-buntansha) 戸口田 淳也  京都大学, ウイルス・再生医科学研究所, 教授 (40273502)
金 永輝  京都大学, 医学研究科, 特定助教 (90620344)
Co-Investigator(Renkei-kenkyūsha) KAWAMOTO Hiroshi  京都大学, ウイルス・再生医科学研究所, 教授 (00343228)
MASUDA Kyoko  京都大学, ウイルス・再生医科学研究所, 助教 (40565777)
Project Period (FY) 2016-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
KeywordsiPS細胞 / 血清反応陰性脊椎関節炎 / HLA B27 / 遺伝子編集 / CRISPR-Cas9 / CXCL13 / 血清反応陰性関節炎 / 強直性脊椎炎 / ゲノム編集
Outline of Final Research Achievements

During this project, we established iPSCs from three patients with ankylosing spondylitis, a seronegative spondyloarthritis. To address pathogenic function of HLA B27, we also successfully established HLA B27 deficient iPSCs from two patients using CRISPR/Cas9 genome-editing. Furthermore, we investigated the role of T cells in human chronic inflammatory diseases, because HLA is most contributing factor to human autoimmune arthritis; and showed that in synovium of rheumatoid arthritis a contrast disease of seronegative spondyloarthritis, transcription factor Sox4 contributes to the pathogenesis of chronic inflammation by CXCL13 production from CD4+ T cells.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • Products Report
  • Research Products

    (7 results)

All 2018 2017

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (6 results) (of which Invited: 4 results)

  • [Journal Article] Human Sox4 facilitates the development of CXCL13-producing helper T cells in inflammatory environments.2018

    • Author(s)
      Yoshitomi H, Kobayashi S, Miyagawa-Hayashino A, Okahata A, Doi K, Nishitani K, Murata K, Ito H, Tsuruyama T, Haga H, Matsuda S, Toguchida J
    • Journal Title

      Nature Communications

      Volume: 9 Issue: 1 Pages: 3762-3762

    • DOI

      10.1038/s41467-018-06187-0

    • NAID

      120006523829

    • Related Report
      Products Report
    • Peer Reviewed / Open Access
  • [Presentation] 整形疾患の創薬基礎研究の現在 ~リウマチ研究からiPS細胞研究まで~2018

    • Author(s)
      吉富啓之
    • Organizer
      第31回上本町整形外科フォーラム
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] 関節リウマチ滑膜炎の炎症病態 -臨床サンプルの解析から-2017

    • Author(s)
      吉富啓之
    • Organizer
      第 16 回関西膠原病フォーラム
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] 炎症環境下 ヒトCD4陽性 T 細胞の転写制御解析2017

    • Author(s)
      吉富啓之、小林志緒、土井浩平、岡畠章憲、伊藤宣、 松田秀一、 戸口田淳也
    • Organizer
      JCRベーシックリサーチカンファレンス
    • Related Report
      2017 Annual Research Report
  • [Presentation] Transcriptional regulation of PD-1+CD4+ T cells under inflammatory conditions2017

    • Author(s)
      吉富啓之、土井浩平、伊藤宣、松田秀一、戸口田淳也
    • Organizer
      第46回日本免疫学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 整形外科関連疾患の創薬基礎研究の現在 ~リウマチ研究からiPS細胞研究まで~2017

    • Author(s)
      吉富啓之
    • Organizer
      第25回西整医病診連携の会
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] 1からわかるiPS細胞 -難病の薬を開発する-2017

    • Author(s)
      吉富啓之
    • Organizer
      NHK文化センター京都教室特別講座
    • Related Report
      2017 Annual Research Report
    • Invited

URL: 

Published: 2016-04-21   Modified: 2019-05-15  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi